Telepharmacy, the remote delivery of pharmaceutical services through information and communication technology,
enhances access to healthcare, improves patient outcomes, and addresses challenges in underserved areas. This
review consolidates evidence from scholarly publications, national health-care documents, and case reports to explore
the global integration and potential of telepharmacies. The COVID-19 pandemic has accelerated telepharmacy
adoption, maintaining high-quality pharmaceutical care while adhering to social distancing. Telepharmacy includes
services, such as patient assessment, medication evaluation, prescription verification, and patient education.
Countries such as Australia, the US, Canada, and the UK have used telepharmacy for decades, especially in rural
areas. Innovative models such as medication consultation systems, WeChat-based services, and Telepharmacy
Robotic Delivery Services improve access to therapies. Studies have shown that telepharmacy has a positive
impact on disease management, medication adherence, and adverse events. Successful deployment of telepharmacy
requires addressing confidentiality, digital literacy, cultural acceptance, and legal support. Collaborative efforts
among health-care professionals and their integration into the existing systems are essential. As healthcare evolves,
telepharmacy is crucial for enhancing clinical safety, expanding pharmaceutical access, and optimizing patient care.